North America Prosthetic Heart Valves Market Current Trends, Size, Share, Industry Analysis, Competitive Intelligence, Growth, Opportunities and Forecasts To 2020 GlobalData's new report, "North America Prosthetic Heart Valves Market Outlook to 2020", provides key market data on the North America Prosthetic Heart Valves market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Mechanical Heart Valves, Tissue Heart Valves and Transcatheter Heart Valves. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Prosthetic Heart Valves market wherever available. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Browse the full “Prosthetic Heart Valves Market� report at: http://www.radiantinsights.com/research/north-america-prosthetic-heart-valves-marketoutlook-to-2020 The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Market size for Prosthetic Heart Valves categories - Mechanical Heart Valves, Tissue Heart Valves and Transcatheter Heart Valves. - Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
- 2012 company shares and distribution shares data for the market category. - Global corporate-level profiles of key companies operating within the North America Prosthetic Heart Valves market. - Key players covered include Edwards Lifesciences Corporation, Medtronic, Inc., St. Jude Medical, Inc., Sorin Group and CryoLife, Inc. Reasons to buy - Develop business strategies by identifying the key market categories and segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize. Table Of Content: 1 Table of Contents 2 1.1 List of Tables 7 1.2 List of Figures 8 To Get Sample Copy of Report visit @ http://www.radiantinsights.com/research/northamerica-prosthetic-heart-valves-market-outlook-to-2020#tabs-4 2 Introduction 10 2.1 What Is This Report About? 10 2.2 Prosthetic Heart Valves Market Segmentation 10 2.3 Definitions of Markets Covered in the Report 11 3 Prosthetic Heart Valves Market, North America 12 3.1 Prosthetic Heart Valves Market, North America, Revenue ($m), 2005-2020 12 3.2 Prosthetic Heart Valves Market, North America, Category Comparison by Revenue ($m), 2005-2020 14 3.3 Prosthetic Heart Valves Market, North America, Revenue ($m), 2005-2012 16 3.4 Prosthetic Heart Valves Market, North America, Revenue ($m), 2012-2020 18 3.5 Prosthetic Heart Valves Market, North America, Volume (Units), 2005-2020 20 3.6 Prosthetic Heart Valves Market, North America, Volume (Units), 2005-2012 21 3.7 Prosthetic Heart Valves Market, North America, Volume (Units), 2012-2020 23 3.8 Prosthetic Heart Valves Market, North America, Company Share by Revenue ($m), 20112012 25 4 Prosthetic Heart Valves Market, Canada 27 4.1 Prosthetic Heart Valves Market, Canada, Revenue ($m), 2005-2012 27
4.2 Prosthetic Heart Valves Market, Canada, Revenue ($m), 2012-2020 29 4.2.1 Mechanical Heart Valves Market, Canada, Revenue ($m), by Segment, 2005-2012 31 4.2.2 Tissue Heart Valves Market, Canada, Revenue ($m), by Segment, 2005-2012 33 4.2.3 Mechanical Heart Valves Market, Canada, Revenue ($m), by Segment, 2012-2020 35 4.2.4 Tissue Heart Valves Market, Canada, Revenue ($m), by Segment, 2012-2020 37 4.3 Prosthetic Heart Valves Market, Canada, Volume (Units), 2005-2012 39 4.4 Prosthetic Heart Valves Market, Canada, Volume (Units), 2012-2020 41 4.4.1 Mechanical Heart Valves Market, Canada, Volume (Units), by Segment, 2005-2012 43 4.4.2 Tissue Heart Valves Market, Canada, Volume (Units), by Segment, 2005-2012 45 4.4.3 Mechanical Heart Valves Market, Canada, Volume (Units), by Segment, 2012-2020 47 4.4.4 Tissue Heart Valves Market, Canada, Volume (Units), by Segment, 2012-2020 49 4.5 Prosthetic Heart Valves Market, Canada, Average Price ($), 2005-2020 51 4.6 Prosthetic Heart Valves Market, Canada, Distribution Share by Revenue ($m), 2011-2012 53 4.7 Prosthetic Heart Valves Market, Canada, Company Share by Revenue ($m), 2011-2012 54 Browse All Reports of This Category @ http://www.radiantinsights.com/catalog/medicaldevices 5 Prosthetic Heart Valves Market, Mexico 56 5.1 Prosthetic Heart Valves Market, Mexico, Revenue ($m), 2005-2012 56 5.2 Prosthetic Heart Valves Market, Mexico, Revenue ($m), 2012-2020 58 5.2.1 Mechanical Heart Valves Market, Mexico, Revenue ($m), by Segment, 2005-2012 60 5.2.2 Tissue Heart Valves Market, Mexico, Revenue ($m), by Segment, 2005-2012 62 5.2.3 Mechanical Heart Valves Market, Mexico, Revenue ($m), by Segment, 2012-2020 64 5.2.4 Tissue Heart Valves Market, Mexico, Revenue ($m), by Segment, 2012-2020 66 5.3 Prosthetic Heart Valves Market, Mexico, Volume (Units), 2005-2012 68 5.4 Prosthetic Heart Valves Market, Mexico, Volume (Units), 2012-2020 70 5.4.1 Mechanical Heart Valves Market, Mexico, Volume (Units), by Segment, 2005-2012 72 5.4.2 Tissue Heart Valves Market, Mexico, Volume (Units), by Segment, 2005-2012 74 5.4.3 Mechanical Heart Valves Market, Mexico, Volume (Units), by Segment, 2012-2020 76 5.4.4 Tissue Heart Valves Market, Mexico, Volume (Units), by Segment, 2012-2020 78 5.5 Prosthetic Heart Valves Market, Mexico, Average Price ($), 2005-2020 80 5.6 Prosthetic Heart Valves Market, Mexico, Distribution Share by Revenue ($m), 2011-2012 82 5.7 Prosthetic Heart Valves Market, Mexico, Company Share by Revenue ($m), 2011-2012 83 6 Prosthetic Heart Valves Market, United States 85 6.1 Prosthetic Heart Valves Market, United States, Revenue ($m), 2005-2012 85 6.2 Prosthetic Heart Valves Market, United States, Revenue ($m), 2012-2020 87 6.2.1 Mechanical Heart Valves Market, United States, Revenue ($m), by Segment, 2005-2012 89 6.2.2 Tissue Heart Valves Market, United States, Revenue ($m), by Segment, 2005-2012 91 6.2.3 Mechanical Heart Valves Market, United States, Revenue ($m), by Segment, 2012-2020 93 6.2.4 Tissue Heart Valves Market, United States, Revenue ($m), by Segment, 2012-2020 95 6.3 Prosthetic Heart Valves Market, United States, Volume (Units), 2005-2012 97 6.4 Prosthetic Heart Valves Market, United States, Volume (Units), 2012-2020 99
6.4.1 Mechanical Heart Valves Market, United States, Volume (Units), by Segment, 2005-2012 101 6.4.2 Tissue Heart Valves Market, United States, Volume (Units), by Segment, 2005-2012 103 6.4.3 Mechanical Heart Valves Market, United States, Volume (Units), by Segment, 2012-2020 105 6.4.4 Tissue Heart Valves Market, United States, Volume (Units), by Segment, 2012-2020 107 6.5 Prosthetic Heart Valves Market, United States, Average Price ($), 2005-2020 109 6.6 Prosthetic Heart Valves Market, United States, Distribution Share by Revenue ($m), 20112012 111 6.7 Prosthetic Heart Valves Market, United States, Company Share by Revenue ($m), 2011-2012 112 7 Overview of Key Companies in North America Prosthetic Heart Valves Market 114 7.1 Edwards Lifesciences Corporation 114 7.1.1 Company Overview 114 7.2 Medtronic, Inc. 114 7.2.1 Company Overview 114 7.3 St. Jude Medical, Inc. 114 7.3.1 Company Overview 114 7.4 Sorin S.p.A. 115 7.4.1 Company Overview 115 Browse full report on: http://www.radiantinsights.com/research/north-america-prostheticheart-valves-market-outlook-to-2020 8 Prosthetic Heart Valves Market Pipeline Products 116 9 Recent Developments 117 9.1 Corporate Communications 117 9.1.1 Apr 08, 2014: CardiAQ Valve Technologies appoints Paul Cornelison as Vice President of Regulatory Affairs, Quality Assurance & Clinical Affairs 117 9.1.2 Jan 28, 2014: St. Jude Medical Announces Organizational and Executive Leadership Changes 117 9.1.3 Jan 07, 2014: Simbionix Welcomes New Latin and Central American Sales Manager 118 9.1.4 Dec 05, 2013: Anxious Patient Group Calls on NICE to Approve Only Drug Treatment for Ultra-Rare Disease 118 9.1.5 Dec 05, 2013: Edwards Lifesciences Announces Appointment of CFO 120 9.1.6 Nov 04, 2013: Canbex Therapeutics Commences Phase I Clinical Trial of Lead Product VSN16R as a Potential Treatment for Spasticity in Multiple Sclerosis 121 9.1.7 Aug 13, 2013: Covidien launches Barrx Channel RFA Endoscopic Catheter 121 9.1.8 Aug 02, 2013: China CDC Enters Into R&D Agreement With Aeras Global For TB Vaccine 122 9.1.9 Jul 22, 2013: St. Jude Medical Appoints Stefan Widensohler to Its Board of Directors 123 9.1.10 Jul 03, 2013: Novartis Files Patent Infringement Lawsuit Against Intas Pharma Over Generic Myfortic 123
9.1.11 May 14, 2013: Edwards Lifesciences CFO Thomas M Abate To Retire 124 9.2 Financial Announcements 124 9.2.1 Apr 24, 2014: Edwards Lifesciences Reports Strong First Quarter Results 124 9.2.2 Apr 16, 2014: St. Jude Medical Reports First Quarter 2014 Results 126 9.2.3 Feb 18, 2014: Medtronic Reports Third Quarter Earnings 128 9.2.4 Feb 03, 2014: Edwards Lifesciences Reports Strong Fourth Quarter Results 129 9.2.5 Jan 22, 2014: St. Jude Medical Reports Fourth Quarter and Full-Year 2013 Results 131 9.2.6 Dec 09, 2013: St. Jude Medical Announces Fourth Quarter Dividend 133 9.2.7 Nov 26, 2013: FDA approves Varithena (polidocanol injectable foam) for the treatment of patients with varicose veins 133 9.2.8 Nov 19, 2013: Medtronic Reports Second Quarter Earnings 134 9.2.9 Nov 11, 2013: Medtronic to Announce Financial Results for Its Second Quarter of Fiscal Year 2014 136 9.2.10 Oct 28, 2013: Edwards Lifesciences Reports Solid Third Quarter Results 136 9.2.11 Oct 16, 2013: St. Jude Medical Reports Third Quarter 2013 Results 138 9.2.12 Oct 02, 2013: St. Jude Medical Announces Third Quarter 2013 Earnings Conference Call 140 9.2.13 Aug 20, 2013: Medtronic Reports First Quarter Earnings 140 9.2.14 Aug 12, 2013: Medtronic to Announce Financial Results for Its First Quarter of Fiscal Year 2014 142 9.2.15 Jul 30, 2013: Teleflex subsidiary receives 510(k) clearance for balloon dilatation catheters 142 Request Free Sample Of This Study @ http://www.radiantinsights.com/research/northamerica-prosthetic-heart-valves-market-outlook-to-2020#tabs-4 9.2.16 Jul 30, 2013: St. Jude Medical Announces Third Quarter Dividend 144 9.2.17 Jul 25, 2013: Edwards Lifesciences Reports Solid Second Quarter Results 144 9.2.18 Jul 17, 2013: St. Jude Medical Reports Second Quarter 2013 Results 146 9.2.19 Jul 11, 2013: Edwards Lifesciences to Host Earnings Conference Call on July 25, 2013 147 9.2.20 Jul 02, 2013: St. Jude Medical Announces Second Quarter 2013 Earnings Conference Call 148 9.2.21 May 21, 2013: Medtronic Reports Revenue Of $16.6 Billion In Fiscal 2013 148 9.2.22 May 10, 2013: New Excimer Laser from ZEISS for Refractive Surgery Reduces Treatment Time to the Benefit Both Doctor and Patient 150 9.3 Government and Public Interest 151 9.3.1 Mar 11, 2014: Simbionix Provides Comprehensive Virtual Reality Training for the Fast Arthroscopy Curriculum 151 9.3.2 Jan 06, 2014: Medtronic CEO Omar Ishrak to Speak at J.P. Morgan Healthcare Conference 152 9.3.3 Dec 18, 2013: St. Jude Medical to Present at the 32nd Annual J.P. Morgan Healthcare Conference 152 9.3.4 Dec 10, 2013: Collaboration Between Simbionix And 1st MSMU To Integrate A Russian Developed Assessment System To Enhance Laparoscopic Training 152
9.3.5 Dec 04, 2013: Medtronic CFO Gary Ellis to Speak at Oppenheimer Healthcare Conference 153 9.3.6 Nov 26, 2013: Medtronic EVP & President Mike Coyle to Speak at Piper Jaffray Healthcare Conference 153 9.3.7 Nov 21, 2013: St. Jude Medical to Present at the Piper Jaffray 25th Annual Healthcare Conference 153 9.3.8 Nov 06, 2013: St. Jude Medical to Present at the 2013 Credit Suisse Healthcare Conference 153 9.3.9 Nov 01, 2013: St. Jude Medical to Present at the 2013 Credit Suisse Healthcare Conference 153. About Us Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of Ancillary services such as, research partnerships/ tie-ups and customized research solutions. Media Contact: Michelle Thoras Corporate Sales Specialist, USA Radiant Insights, Inc Phone: 1-415-349-0054 Toll Free: 1-888-202-9519 Email: sales@radiantinsights.com Website: Radiant Insights Visit Our Blog: radiantri.blogspot.com